Dr. Teresa Purzner received her MD in 2009, then completed the first 4 years of her neurosurgical residency in Toronto before leaving the clinical realm to study developmental neurobiology at Stanford University. During her time at Stanford, Teresa combined novel techniques in mass spectrometry with developmental neurobiology to discover new drug targets for pediatric brain tumors. This led to her discovering a new drug target in medulloblastoma, the most common pediatric brain tumor. In collaboration with Stanford SPARK and the pediatric brain tumor consortium (PBTC), she bridged this discovery from bench to bedside in the form of a first-in-child CK2 inhibitor clinical trial for the treatment of medulloblastoma. Dr. Purzner’s work has earned her widespread recognition both in the media and through national and international awards including the Stanford Interdisciplinary Graduate and BioX fellowship, Annual Award of the American Academy of Neurological Surgery, the Weston Havens Foundation award, K.G. McKenzie prize for Basic Science Research, AANS Louise Eisenhardt Award and the Neurosurgery Research and Education Fellowship. She is also the founder and CSO of Cerebelly, a babyfood company designed to support early brain development which can be found in over 15,000 stores across Canada and the USA, including Loblaws, Sobey’s, Farm Boy, Whole Foods Market, Target, Kroger and Wegmans.